Assignee
ALFASIGMA SPA
IT20 patents
Top patents by PatentIndex Score
US12042498B2Jul 23, 2024
Compound useful for the treatment of degenerative and inflammatory diseases
ALFASIGMA SPA5 citations85
US12234235B2Feb 25, 2025
Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
ALFASIGMA SPA2 citations70
US12558360B2Feb 24, 2026
Compound useful for the treatment of degenerative and inflammatory diseases
ALFASIGMA SPA0 citations62
US12502394B2Dec 23, 2025
Pharmaceutical compositions comprising a JAK inhibitor
ALFASIGMA SPA0 citations59
US12447183B2Oct 21, 2025
Bacterial strains, their compositions and their use for the treatment of gastrointestinal disorders
ALFASIGMA SPA0 citations59
US11752179B2Sep 12, 2023
Medical use of probiotics
ALFASIGMA SPA0 citations58
US12201729B2Jan 21, 2025
Process for mesalazine solid formulations
ALFASIGMA SPA0 citations57
US11839634B2Dec 12, 2023
Use of a composition comprising microorganisms to increase the intestinal production of butyric acid, folic acid or niacin and/or decrease the intestinal production of succinic acid
ALFASIGMA SPA0 citations57
US11241452B2Feb 8, 2022
Oral compositions for the treatment of gastroesophageal reflux
ALFASIGMA SPA0 citations55
US10703763B2Jul 7, 2020
Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
ALFASIGMA SPA0 citations51
US11433043B2Sep 6, 2022
Compounds useful for increasing neurogenesis in neural tissue
ALFASIGMA SPA0 citations49
US10280177B2May 7, 2019
Use of polyols to obtain stable polymorphous forms of rifaximin
ALFASIGMA SPA0 citations49
US12472214B2Nov 18, 2025
Bacterial strains, the compositions thereof and use thereof in a method for the treatment of vitamin D deficiency, and disorders associated therewith
ALFASIGMA SPA0 citations48
US11751597B2Sep 12, 2023
Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems
ALFASIGMA SPA0 citations48
US11896631B2Feb 13, 2024
Probiotics for use in the treatment of diverticulosis and diverticular disease
ALFASIGMA SPA0 citations47
US10285944B2May 14, 2019
Gastroresistant pharmaceutical formulations containing rifaximin
ALFASIGMA SPA0 citations47
US10428086B2Oct 1, 2019
Solvated crystal form of rifaximin, production, compositions and uses thereof
ALFASIGMA SPA0 citations46
US10793925B2Oct 6, 2020
Lactobacillus paracasei for the production of conjugated linoleic acid, nutritional and pharmaceutical preparations containing it and uses thereof
ALFASIGMA SPA0 citations43
US12329758B2Jun 17, 2025
Methods for the treatment of psoriatic arthritis
ALFASIGMA SPA0 citations42
US10300035B2May 28, 2019
Homogeneous formulation comprising omega-3 polyunsatured fatty acid and resveratrol for oral administration
ALFASIGMA SPA0 citations42